dotMD.com
Find a Doctor
Health Research, In Plain English • 5,828 Stories

Medical breakthroughs, translated for real life.

Every story explains a peer-reviewed clinical trial or medical journal report at a clear, 8th-grade reading level—with 15-second takeaways, participant counts, Study Rigor Scores, and a direct link to the formal paper.

All Research Stories Phase III Randomized Trial (3,355) Randomized Controlled Trial (1,799) Meta-Analysis (566) Peer-Reviewed Journal (Clinical Trials) (39) FDA Drug Recall (Class II) (15) Completed Human Clinical Trial (NCT) (15) FDA Safety Alert (13) FDA Recall (12) Peer-Reviewed Journal (Longevity & Biotech) (8) Clinical Trial (4) Clinical Pharmacology Review (1) Systematic Review (1)
Live Journal & Safety Desks: JAMA Network New England Journal of Medicine The Lancet BMJ Recent Research Nature Medicine FDA MedWatch Safety Alerts FDA Drug Recalls
Randomized Controlled Trial • Acta anaesthesiologica Scandinavica • 2027-01-15

Calmer Recovery After Surgery: How This Sedative Steadies Breathing and Heart Rate

Dexmedetomidine as an add-on booster to oxycodone PCA produced transient blood flow and heart rate effects without differences in slow heart rate or in the measured breathing variables.

Read Plain-English Story | Formal Study: “Haemodynamic and Respiratory Effects of Dexmedetomidine as an Adjuvant to Oxycodone Patient-Controlled Analgesia After Lumbar Spinal Fusion: A Post Hoc Analysis of the DoseRespDex Randomised Controlled Trial”
N = 98 Rigor 88/100
Formal Study (PMID #42929478)
Randomized Controlled Trial • Physiotherapy research international : the journal for researchers and clinicians in physical therapy • 2027-01-15

The Surprising Brain-and-Balance Trick That Could Keep You Steady on Your Feet

In ambulatory children with spastic diplegic CP (GMFCS Levels I-II), adding BW to DTT was associated with a small additional improvement in functional mobility over 4 weeks (approximately 1 s on the TUG) of uncertain clinical...

Read Plain-English Story | Formal Study: “Effects of Dual-Task Training With and Without Backward Walking on Balance, Functional Mobility, and Participation in Ambulatory Children With Spastic Diplegic Cerebral Palsy: A Randomized Controlled Trial”
Rigor 82/100
Formal Study (PMID #42967331)
Randomized Controlled Trial • Pakistan journal of pharmaceutical sciences • 2027-01-01

Could Berberine Help Stubborn Diabetic Foot Sores Heal Faster? Early Trial Offers Hope

In DF patients undergoing TTO, adjunctive local berberine therapy significantly improves the total effective rate and promotes ulcer healing, with benefits associated with reduced inflammation and fibroblast apoptosis and...

Read Plain-English Story | Formal Study: “Berberine improves diabetic foot ulcer healing after tibial transverse osteotomy by inhibiting the PDGF-B/PDGFRβ signaling pathway”
N = 48 Rigor 88/100
Formal Study (PMID #42924998)
Randomized Controlled Trial • Pakistan journal of pharmaceutical sciences • 2027-01-01

Targeted Pain Relief Without Stomach Upset: How Well Do Diclofenac Skin Patches Work?

A short-course applied to the skin diclofenac epolamine patch, combined with rehabilitation training, effectively alleviates pain, accelerates functional recovery, and is safe for treating moderate hamstring strain, supporting...

Read Plain-English Story | Formal Study: “Efficacy and safety study of diclofenac epolamine topical patch in accelerating rehabilitation of moderate hamstring strain: A randomized controlled trial”
N = 120 Rigor 88/100
Formal Study (PMID #42924980)
Meta-Analysis • Journal of bronchology & interventional pulmonology • 2027-01-01

Faster Wake-Up After a Procedure: How a Newer Sedative Compares to Standard Anesthesia

Remimazolam provides effective sedation for fiberoptic bronchoscopy with advantages in terms of breathing and blood flow and heart rate safety, rapid recovery, and procedural efficiency.

Read Plain-English Story | Formal Study: “Comparison of the Safety and Efficacy of Remimazolam for Sedation in Adults Undergoing Fiberoptic Bronchoscopy: A Meta-Analysis of Randomized Controlled Trials”
Rigor 86/100
Formal Study (PMID #42935012)
Phase III Randomized Trial • Hematology (Amsterdam, Netherlands) • 2026-12-31

Living Longer With Bone Marrow Scarring: What 2,233 Patients Taught Doctors About Ruxolitinib

Results support use of anemia-supporting medications with ruxolitinib and may allow maintenance of ruxolitinib dose intensity in patients with myelofibrosis and anemia.

Read Plain-English Story | Formal Study: “Outcomes of patients with myelofibrosis treated with ruxolitinib and anemia-supporting medications”
N = 2,233 Rigor 90/100
Formal Study (PMID #42698151)
Meta-Analysis • Oncoimmunology • 2026-12-31

When Only One Tumor Spot Grows During Immunotherapy: Can Pinpoint Treatment Keep It Working?

The evidence is predominantly observational and of low certainty, reflecting the current absence of NSCLC-specific randomized trials.

Read Plain-English Story | Formal Study: “Local ablative treatment for oligoprogression during immunotherapy in metastatic non-small-cell lung cancer: a systematic review and meta-analysis”
Rigor 86/100
Formal Study (PMID #42965526)
Randomized Controlled Trial • Journal of the International Society of Sports Nutrition • 2026-12-30

How Much Pre-Workout Caffeine Is Too Much? What Blood Tests Reveal About High Doses

These findings suggest that acute CAF ingestion selectively influences post-exercise glucose responses during the CrossFit ® workout, whereas hematological variables and most biochemical markers remain unaffected.

Read Plain-English Story | Formal Study: “Hematological and biochemical responses to three doses of caffeine during the CrossFit® workout: a randomized, double-blind, crossover trial”
Rigor 88/100
Formal Study (PMID #42924484)
Meta-Analysis • Journal of the International Society of Sports Nutrition • 2026-12-30

Plant Protein vs. Whey: Which One Actually Builds Muscle Better?

Soy- and pea-based protein supplements may support favorable muscle and body-fat improvements in adults strength training and could be considered practical nutritional options for individuals seeking alternatives to whey protein.

Read Plain-English Story | Formal Study: “Is plant-based protein supplementation as effective as whey protein? A systematic review and meta-analysis in untrained adults undergoing resistance training”
Rigor 86/100
Formal Study (PMID #42954267)
Phase III Randomized Trial • Human vaccines & immunotherapeutics • 2026-12-15

Can You Get Your RSV and Flu Shots at the Same Visit? What a 1,900-Adult Trial Found

Coadminstration is estimated to maintain the efficacy of mRNA-1345 against RSV-lower breathing tract disease based on a correlate of protection model.

Read Plain-English Story | Formal Study: “Coadministration of mRNA-1345 RSV vaccine with high-dose quadrivalent influenza vaccine in adults aged 65 and older: An observer-blinded, placebo-controlled, randomized, phase 3 trial”
N = 1,900 Rigor 96/100
Formal Study (PMID #42048601)
Meta-Analysis • Global health research and policy • 2026-12-15

Why So Many Heart Failure Patients Miss Their Meds—and Simple Ways to Stay on Track

Approximately two in five heart failure patients in Africa are non-adherent to their medication, with prevalence rates varying significantly by region.

Read Plain-English Story | Formal Study: “Medication non-adherence and its associated factors among heart failure patients in Africa: A systematic review and meta-analysis”
N = 6,276 Rigor 94/100
Formal Study (PMID #42964796)
Phase III Randomized Trial • The Journal of dermatological treatment • 2026-12-15

Stubborn Plaque Psoriasis? A Targeted New Antibody Cleared Skin in a 461-Patient Trial

Vunakizumab shows satisfactory efficacy in patients with moderate-to-severe plaque psoriasis skin flare-ups skin flare-ups, regardless of psoriasis duration and severity.

Read Plain-English Story | Formal Study: “Efficacy of vunakizumab in patients with moderate-to-severe plaque psoriasis across diverse disease features: a post hoc analysis of a phase-III trial”
N = 461 Rigor 93/100
Formal Study (PMID #42333837)
Randomized Controlled Trial • Pharmaceutical biology • 2026-12-15

Kids With the Flu: How an Herbal Remedy Stacked Up Against Tamiflu in a 520-Child Trial

LHQW was non-inferior to oseltamivir in clinical recovery time and resulted in faster defervescence and greater improvement in cough and sore throat, with comparable safety.

Read Plain-English Story | Formal Study: “Efficacy and safety of Lianhua Qingwen versus oseltamivir in children with influenza: a multicenter, randomized, double-blind, positive parallel-controlled study”
N = 520 Rigor 93/100
Formal Study (PMID #42947434)
Phase III Randomized Trial • Human vaccines & immunotherapeutics • 2026-12-15

New Insights on Mutual effects on safety and immunogenicity of combined vaccination with: What a 1,110-Participant Study Found

Incidence of AEs in P+DTP group was lower than P-DTP group and slightly higher than DTaP group.

Read Plain-English Story | Formal Study: “The mutual effects on safety and immunogenicity of combined vaccination with 15-valent pneumococcal conjugate vaccine and adsorbed acellular DPT in 3-month healthy infants: A randomized, open-label, controlled, phase III clinical trial”
N = 1,110 Rigor 90/100
Formal Study (PMID #42546220)
Phase III Randomized Trial • Human vaccines & immunotherapeutics • 2026-12-15

Protecting Teens and Young Adults From Meningitis: Inside a 2,080-Person Vaccine Trial

This study supports the safety profile of MenACYW-TT in infants and toddlers aged ≥ 6 weeks.

Read Plain-English Story | Formal Study: “Safety of a quadrivalent meningococcal conjugate vaccine (MenACYW-TT) administered concomitantly with routine pediatric vaccines in healthy infants and toddlers in USA and Puerto Rico: Results from a Phase III, randomized, active-controlled study”
N = 2,080 Rigor 90/100
Formal Study (PMID #42642862)
Phase III Randomized Trial • Human vaccines & immunotherapeutics • 2026-12-15

New Insights on Immune correlates analysis in NextCOVE trial for a next-generation mRNA-1283: What a 10,000-Participant Study Found

The estimated hazard ratios per 10-fold increase in Day 29 nAbs against D614G, BA.4/BA.5, and XBB.1.5 were 0.70 (95% confidence interval [CI]: 0.48-1.02; p = .064), 0.49 (95% CI: 0.41-0.58; p p < .001), respectively.

Read Plain-English Story | Formal Study: “Immune correlates analysis in NextCOVE trial for a next-generation mRNA-1283 COVID-19 vaccine”
N = 10,000 Rigor 90/100
Formal Study (PMID #42220116)
Phase III Randomized Trial • The Journal of dermatological treatment • 2026-12-15

Can This Approach Help? Inside the Latest Research on Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe

Stapokibart reduced blood eosinophil counts in AD patients and demonstrated favorable real-world benefits and safety regardless of baseline blood eosinophil counts.

Read Plain-English Story | Formal Study: “Stapokibart reduces blood eosinophil counts in patients with moderate-to-severe atopic dermatitis: a post-hoc analysis from phase II and phase III clinical trials”
N = 120 Rigor 88/100
Formal Study (PMID #42454692)
Phase III Randomized Trial • The Journal of dermatological treatment • 2026-12-15

Can This Approach Help? Inside the Latest Research on Stapokibart provides significant improvements in signs and symptoms of eczema

Stapokibart demonstrated significant clinical efficacy and manageable safety in AD patients irrespective of prior systemic treatment.

Read Plain-English Story | Formal Study: “Stapokibart provides significant improvements in signs and symptoms of atopic dermatitis irrespective of prior systemic treatment: a post-hoc analysis of a phase 3 trial”
Rigor 88/100
Formal Study (PMID #42403221)
Phase III Randomized Trial • The Journal of dermatological treatment • 2026-12-15

Can This Approach Help? Inside the Latest Research on Sustained on/off-treatment disease control with abrocitinib for

After 12 weeks of abrocitinib 200 mg, some patients achieved 40 weeks of sustained off-treatment disease control, with assessments demonstrating clear/mild AD, suggesting attainment of disease full symptom relief.

Read Plain-English Story | Formal Study: “Sustained on/off-treatment disease control with abrocitinib for moderate-to-severe atopic dermatitis”
Rigor 88/100
Formal Study (PMID #42165315)
Randomized Controlled Trial • The Journal of dermatological treatment • 2026-12-15

Can This Approach Help? Inside the Latest Research on Safety, tolerability, and how the body absorbs the medicine of CG2001 in Chinese

The result shows that CG2001 was safe and well-tolerated, with no serious side effects.

Read Plain-English Story | Formal Study: “Safety, tolerability, and pharmacokinetics of CG2001 in Chinese adult male subjects with androgenetic alopecia: a randomized, double-blind, placebo-controlled, single- and multi-doses, phase 1 clinical study”
Rigor 88/100
Formal Study (PMID #41622844)
Phase III Randomized Trial • Journal of child and adolescent psychopharmacology • 2026-12-15

Can This Approach Help? Inside the Latest Research on Benefits and safety of Trimodal Dexmethylphenidate (CTx-1301) in Children and

CTx-1301 demonstrated dose-related improvements in signs and symptoms of ADHD, although statistical significance is not consistent across all dose groups.

Read Plain-English Story | Formal Study: “Efficacy and Safety of Trimodal Dexmethylphenidate (CTx-1301) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Results From a Phase 3, Randomized, Double-Blind, Fixed-Dose, Placebo-Controlled Trial”
N = 103 Rigor 88/100
Formal Study (PMID #42484049)
Phase III Randomized Trial • Human vaccines & immunotherapeutics • 2026-12-15

Can This Approach Help? Inside the Latest Research on Safety and durability of influenza and SARS-CoV-2 antibody responses through 6

These findings support the use of mRNA-1083 as a multicomponent vaccine.

Read Plain-English Story | Formal Study: “Safety and durability of influenza and SARS-CoV-2 antibody responses through 6 months after a single dose of mRNA-1083, a multicomponent influenza and COVID-19 vaccine, in adults ≥50 years”
Rigor 88/100
Formal Study (PMID #42213900)
Phase III Randomized Trial • Asia-Pacific journal of clinical oncology • 2026-12-15

Can This Approach Help? Inside the Latest Research on Efficacy of Dexamethasone Versus N-Acetylcysteine in Prevention of

PES incidence was non-inferior between groups.

Read Plain-English Story | Formal Study: “The Efficacy of Dexamethasone Versus N-Acetylcysteine in Prevention of Post-Embolization Syndrome in Hepatocellular Carcinoma Patients: A Multicenter Randomized, Double-Blind, Double-Dummy, Non-Inferiority Trial”
N = 85 Rigor 88/100
Formal Study (PMID #42260068)
Phase III Randomized Trial • The Journal of dermatological treatment • 2026-12-15

Can This Approach Help? Inside the Latest Research on Ivarmacitinib in patients with moderate to severe eczema stratified by baseline

Ivarmacitinib demonstrated efficacy and good tolerability in treating moderate to severe AD with diverse patient characteristics.

Read Plain-English Story | Formal Study: “Ivarmacitinib in patients with moderate to severe atopic dermatitis stratified by baseline characteristics: a post-hoc analysis of a phase 3 clinical trial”
Rigor 88/100
Formal Study (PMID #41612798)
Randomized Controlled Trial • Musculoskeletal care • 2026-12-15

Can This Approach Help? Inside the Latest Research on Benefits and safety of Ushaq Capsule as add-on treatment in Patients With Lumbar

Ushaq capsules as add-on treatment with diclofenac as rescue medication showed greater pain reduction compared to placebo with a favourable safety profile.

Read Plain-English Story | Formal Study: “Efficacy and Safety of Ushaq Capsule as Adjunctive Therapy in Patients With Lumbar Radiculopathy: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial at Imam Khomeini Hospital, Tehran, Iran”
N = 68 Rigor 88/100
Formal Study (PMID #42935088)
Phase III Randomized Trial • Human vaccines & immunotherapeutics • 2026-12-15

New Insights on A phase 3, randomized study to evaluate the safety, tolerability, and: What a 531-Participant Study Found

In children and adolescents aged 2 to <18 y with certain medical conditions, V116 is well tolerated and immunogenic.

Read Plain-English Story | Formal Study: “A phase 3, randomized study to evaluate the safety, tolerability, and immunogenicity of V116 in children and adolescents with increased risk of pneumococcal disease (STRIDE-13)”
N = 531 Rigor 87/100
Formal Study (PMID #42334402)
Meta-Analysis • Stress and health : journal of the International Society for the Investigation of Stress • 2026-12-15

What the Latest Evidence Really Says About Heterogeneity in Depression and Suicidality Risk Among Vitiligo

Vitiligo is significantly associated with elevated risks of depression and suicidality.

Read Plain-English Story | Formal Study: “Heterogeneity in Depression and Suicidality Risk Among Vitiligo Patients: A Meta-Analysis of Adolescent Complexity and Subgroup Stratification”
Rigor 86/100
Formal Study (PMID #42952473)
Meta-Analysis • Journal of human nutrition and dietetics : the official journal of the British Dietetic Association • 2026-12-15

What the Latest Evidence Really Says About Walnut Consumption on Inflammatory Cytokines and Adipokines in

Walnut consumption may be associated with small reductions in CRP and IL-6 levels, without significant effects on TNF-α or adipokine concentrations.

Read Plain-English Story | Formal Study: “Effects of Walnut Consumption on Inflammatory Cytokines and Adipokines in Adults: A Systematic Review and Dose-Response Meta-Analysis”
Rigor 86/100
Formal Study (PMID #42947498)
Meta-Analysis • Human fertility (Cambridge, England) • 2026-12-15

What the Latest Evidence Really Says About Effectiveness of theory-based educational interventions on fertility and

Theory-based interventions, especially those grounded in the TPB, were associated with higher fertility intentions among Iranian couples.

Read Plain-English Story | Formal Study: “Effectiveness of theory-based educational interventions on fertility and childbearing intentions: a systematic review and meta-analysis among Iranian populations”
Rigor 86/100
Formal Study (PMID #42935436)
Meta-Analysis • Annals of medicine • 2026-12-15

What the Latest Evidence Really Says About Endpoint-specific mortality associated with malignancy among adults with sepsis

Malignancy was associated with higher mortality among adults with sepsis or septic shock, with variation across mortality endpoints and clinical contexts.

Read Plain-English Story | Formal Study: “Endpoint-specific mortality associated with malignancy among adults with sepsis or septic shock: a systematic review and meta-analysis”
Rigor 86/100
Formal Study (PMID #42960561)
Meta-Analysis • Musculoskeletal care • 2026-12-15

What the Latest Evidence Really Says About Meta-Analysis of Randomized Clinical Trials Comparing the Effectiveness of

This meta-analysis suggests that corticosteroid injections may offer better and faster symptom relief in individuals with mild to moderate CTS for a period of up to 8 weeks.

Read Plain-English Story | Formal Study: “A Systematic Review and Meta-Analysis of Randomized Clinical Trials Comparing the Effectiveness of Corticosteroid Injection Versus Night Splints in Patients With Carpal Tunnel Syndrome”
Rigor 86/100
Formal Study (PMID #42947526)
Phase III Randomized Trial • The Journal of dermatological treatment • 2026-12-15

Can This Approach Help? Inside the Latest Research on Early response to ivarmacitinib and its impact on long-term efficacy in patients

Early response to ivarmacitinib at W4 yields better long-term efficacy in patients with moderate-to-severe AD.

Read Plain-English Story | Formal Study: “Early response to ivarmacitinib and its impact on long-term efficacy in patients with moderate-to-severe atopic dermatitis: a post hoc analysis of a phase-III trial”
Rigor 82/100
Formal Study (PMID #42454646)
Randomized Controlled Trial • The Journal of dermatological treatment • 2026-12-15

Can This Approach Help? Inside the Latest Research on Benefits and safety of oral finasteride versus dutasteride in moderate-to-severe

Finasteride and dutasteride improved hair density with similar safety.

Read Plain-English Story | Formal Study: “Efficacy and safety of oral finasteride versus dutasteride in moderate-to-severe androgenetic alopecia in males based on trichoscopic and laboratory findings: a clinical comparison in Iran”
N = 46 Rigor 82/100
Formal Study (PMID #42466626)
Randomized Controlled Trial • International journal of methods in psychiatric research • 2026-12-15

Can This Approach Help? Inside the Latest Research on Effect of Blonanserin on Neurotrophic Factors in Patients With Non-Responsive

Blonanserin can effectively relieve the symptoms of schizophrenia and improve the quality of life of first-episode schizophrenia patients who have failed to respond to Risperidone single-drug treatment in the early stage.

Read Plain-English Story | Formal Study: “Effect of Blonanserin on Neurotrophic Factors in Patients With Non-Responsive First-Episode Schizophrenia Treated With Early Risperidone Monotherapy-A Randomized Controlled Trial”
N = 120 Rigor 82/100
Formal Study (PMID #42963905)
Randomized Controlled Trial • Musculoskeletal care • 2026-12-15

Can This Approach Help? Inside the Latest Research on A Short Evidence-Based, Belief-Focused Educational Video Improves Back Pain

A brief educational video effectively improved back pain beliefs but did not alter lifting behaviour or spinal motion.

Read Plain-English Story | Formal Study: “A Short Evidence-Based, Belief-Focused Educational Video Improves Back Pain Beliefs but Not Lifting Behaviour in Healthy Office Workers: An Exploratory Randomised Controlled Trial”
Rigor 82/100
Formal Study (PMID #42924901)
Phase III Randomized Trial • Human vaccines & immunotherapeutics • 2026-12-15

Can This Approach Help? Inside the Latest Research on Controlled trial evaluating immunogenicity and safety of a porcine

GMC ratio did not meet non‑inferiority: ratio 0.71 (95% CI 0.60-0.84; p : CTR2023189.

Read Plain-English Story | Formal Study: “Randomized controlled trial evaluating immunogenicity and safety of a porcine circovirus-free rotavirus vaccine in healthy Chinese infants”
Rigor 82/100
Formal Study (PMID #42390459)
Randomized Controlled Trial • Clinical implant dentistry and related research • 2026-12-15

Can This Approach Help? Inside the Latest Research on Treatment of Small Peri-Implant Buccal Dehiscence Defects With SCTG or GBR:

Within the limitations of this pilot study, both SCTG and GBR were associated with stable buccal contour conditions and favorable peri-implant health over a 3-year follow-up period.

Read Plain-English Story | Formal Study: “Treatment of Small Peri-Implant Buccal Dehiscence Defects With SCTG or GBR: 3-Year Results of a Pilot Study”
N = 16 Rigor 82/100
Formal Study (PMID #42958619)
Phase III Randomized Trial • The Journal of dermatological treatment • 2026-12-15

Can This Approach Help? Inside the Latest Research on Long-term efficacy of lebrikizumab in treating head, neck and face involvement in

Lebrikizumab provided durable, stable long-term HNF efficacy across diverse populations, including systemic-naive patients and those with prior biologic exposure.

Read Plain-English Story | Formal Study: “Long-term efficacy of lebrikizumab in treating head, neck and face involvement in patients with moderate-to-severe atopic dermatitis”
Rigor 82/100
Formal Study (PMID #42895209)
Randomized Controlled Trial • Public health research & practice • 2026-12-10

Can This Approach Help? Inside the Latest Research on An integrated Healthy Lifestyle Program (HeLP) and physiotherapy care for low

HeLP was acceptable, although uptake varied across components.

Read Plain-English Story | Formal Study: “An integrated Healthy Lifestyle Program (HeLP) and physiotherapy care for low back pain: a mixed methods process evaluation”
N = 174 Rigor 82/100
Formal Study (PMID #42967229)